Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR

International Journal of Cancer

Volumn 113, Issue 2, 2005, Pages 213-220

  Du, Jingping ^a   Pan, Yanglin ^a   Shi, Yongquan ^a   Guo, Changcun ^a   Jin, Xiaohang ^a   Sun, Li ^a   Liu, Na ^a   Qiao, Taidong ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Gastric neoplasm; MDR; PrPc; RNAi

Indexed keywords

DOXORUBICIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; PRION PROTEIN; PROTEIN BAX; PROTEIN BCL 2; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TECHNOLOGY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NUCLEIC ACID PROBE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION;

ADENOCARCINOMA; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CALCIUM CHANNEL BLOCKERS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; PHENOTYPE; PRPC PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION; VERAPAMIL;

EID: 10344251498     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20570     Document Type: Article

References (31)

1. Wechselberger C, Wurm S, Pfarr W, Hoglinger O. The physiological functions of prion protein. Exp Cell Res 2002;281:1-8.
2. Westaway D, Carlson GA. Mammalian prion proteins: enigma, variation and vaccination. Trends Biochem Sci 2002;27:301-7.
3. Martins VR, Linden R, Prado MA, Walz R, Sakamoto AC, Izquierdo I, Brentani RR. Cellular prion protein: on the road for functions. FEBS Lett 2002;512:25-8.
4. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994;8:121-7.
5. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schurmann P, Windl O, Brose N, Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999;19:8866-75.
6. Colling SB, Collinge J, Jefferys JG. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996;209:49-52.
7. Mabbott NA, Brown KL, Manson J, Bruce ME. T-lymphocyte activation and the cellular form of the prion protein. Immunology 1997;92:161-5.
8. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000;289:1925-8.
9. Spielhaupter C, Schatzl HM. PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 2001;276:44604-12.
10. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002;21:3317-26.
11. Bounha Y, Zhang Y, Goodyer CG, LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001;276:39145-9.
12. Ford MJ, Burton LJ, Morris RJ, Hall SM. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002;113:177-92.
13. Fournier, JG. Nonneuronal cellular prion protein. Int Rev Cytol 2001;208:121-60.
14. Pammer J, Cross HS, Frobert Y, Tschachler E, Oberhuber G. The pattern of prion-related protein expression in the gastrointestinal tract. Virchows Arch 2000;436:466-72.
15. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, Fan D. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002;185:211-8.
16. An H, Zhou S, Fan D. Establishment and characteristics of an adriamycin resistant human gastric carcinoma cell line, J Digestive Dis Endosc 1997;2:108-13.
17. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A 2002;99:6047-52.
18. Suonio E, Lipponen P, Maenpaa J, Syrjanen K, Kangas L, Tuomisto L. Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer. Cancer Chemother Pharmacol 1997;41:15-21.
19. Shi Y, Han Y, Wang X, Zhao Y, Ning X, Xiao B, Fan D. MGrl-Ag is associated with multidrug-resistant phenotype of gastric cancer cells. Gastric Cancer 2002;5:154-9.
20. Grusch M, Fritzer-Szekeres M, Fuhrmann G, Rosenberger G, Luxbacher C, Elford HL, Smid K, Peters GJ, Szekeres T, Krupitza G. Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox. Exp Hematol 2001;29:623-32.
21. Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H, Lehmann S, Favier A. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 2003;278:9064-72.
22. Rieger R, Edenhofer F, Lasmezas CI, Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med 1997;3:1383-8.
23. Massimino ML, Griffoni C, Spisni E, Toni M, Tomasi V. Involvement of caveolae and caveolae-like domains in signalling, cell survival and angiogenesis. Cell Signal 2002;14:93-8.
24. Herms JW, Madlung A, Brown DR, Kretzschmar HA. Increase of intracellular free Ca2+ in microglia activated by prion protein fragment. Glia 1997;21:253-7.
25. Satoh J, Kuroda Y, Katamine S. Gene expression profile in prion protein-deficient fibroblasts in culture. Am J Pathol 2000;157:59-68.
26. Levenson VV, Davidovich IA, Roninson IB. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response. Cancer Res 2000;60:5027-30.
27. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T. Prions prevent neuronal cell-line death. Nature 1999;400:225-6.
28. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002;2:277-88.
29. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999;17:2941-53.
30. Shtil AA. Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells. Curr Drug Targets 2001;2:57-77.
31. Brown DR, Nicholas RS, Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002;67:211-24.